Grigeo (GRG1L) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
25 Aug, 2026Executive summary
Revenue rose by EUR 38.5 million (33%) year-over-year for the six months ended 30 June 2026, reaching EUR 155.2 million.
EBITDA declined by EUR 1.5 million (10%) to EUR 14.2 million, and profit before tax (EBT) fell by EUR 2.6 million (27%) to EUR 7.1 million.
Growth in the tissue paper segment was driven by the acquisition of Huchtemeier Papier GmbH, while profitability was impacted by rising energy costs.
Financial highlights
Net profit for the period was EUR 6.3 million, down from EUR 9.1 million year-over-year.
Gross margin decreased to 18.2% from 21.0% year-over-year.
Adjusted EBITDA for the period was EUR 14.2 million, compared to EUR 15.8 million in the prior year.
Earnings per share were EUR 0.047, down from EUR 0.069 year-over-year.
Dividends paid during the period totaled EUR 6.6 million.
Outlook and guidance
The tissue paper segment is expected to continue benefiting from the integration of Huchtemeier Papier GmbH.
Ongoing market challenges and high energy prices are anticipated to pressure margins across segments.
Latest events from Grigeo
- Revenue surged 31% but profit margins and net profit declined amid rising costs and legal risks.GRG1L
Q1 2026 - Revenue up 16% YoY, but profit and margins fell; expansion and legal risks remain.GRG1L
Q4 2025 - Revenue up 9% but margins and net profit declined amid legal and geopolitical risks.GRG1L
Q3 2025 - Revenue up 12% but profit and margins down; EUR 106m tissue investment planned.GRG1L
Q2 2025 - Revenue up, but profit and margins down; legal and geopolitical risks remain elevated.GRG1L
Q3 2024 - EBITDA and net profit fell despite revenue growth, with margin pressure and legal risks ongoing.GRG1L
Q2 2024 - Revenue up 22% but margins and profit before tax declined amid ongoing legal risks.GRG1L
Q1 2025 - Revenue up 9% but profit down 13% amid margin pressure and legal risks.GRG1L
Q4 2024